CD80 and cancer: Our observation that the adenoviral vector Ad5FB4 interacted with cell surface molecules of the B7 family known to be implicated in immunoevasion mechanisms offers novel opportunities for cancer therapy using B7-H1/B7.1 heterodimers as cell surface targets, and Ad5FB4 vectors or Ad5FB4 penton capsomeres as therapeutic agents.